Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

VIR BIOTECHNOLOGY, INC.

(VIR)
  Report
Delayed Nasdaq  -  04:00 2022-12-06 pm EST
25.62 USD   -3.58%
11/17Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500
AQ
11/16Vir Biotechnology Ranked the Fastest-Growing Company in North America on theá2022 Deloitte Technology Fast 500™
GL
11/16Vir Biotechnology Ranked the Fastest-Growing Company in North America on theá2022 Deloitte Technology Fast 500™
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart VIR BIOTECHNOLOGY, INC.
Upcoming events on VIR BIOTECHNOLOGY, INC.
02/23/23 FY 2022 Earnings Release (Projected)
05/04/23 Q1 2023 Earnings Release (Projected)
08/03/23 Interim 2023 Earnings Release (Projected)
11/02/23 Q3 2023 Earnings Release (Projected)
Past events on VIR BIOTECHNOLOGY, INC.
11/06/22 | 01:00pm American Association for the Study of Liver Diseases The Liver Meeting - Sacha Satram
11/06/22 | 12:00pm American Association for the Study of Liver Diseases The Liver Meeting - Kosh Agarwal
11/06/22 | 10:15am American Association for the Study of Liver Diseases The Liver Meeting - Man-Fung Yuen
11/06/22 | 09:00am American Association for the Study of Liver Diseases The Liver Meeting - Edward Gane
11/03/22 | 03:03pm Q3 2022 Earnings Release
10/18/22 | 01:30pm H.C. Wainwright Hepatitis B Virus (HBV) Conference
09/13/22 | 04:05pm Morgan Stanley Global Healthcare Conference
08/09/22 | 04:02pm Interim 2022 Earnings Release
06/25/22 | 04:00am European association for the study of the liver international liver congress - abstract no : #654
06/25/22 | 03:00am European association for the study of the liver international liver congress - abstract no : #644
Past dividends on VIR BIOTECHNOLOGY, INC.

- No events available -

Annual results
Fiscal Period : December2019202020212022
Sales
M $
Released
Forecast
Spread
8,09
9,15
-12%
76,4
79,3
-3,7%
1 095
906
21%
 
1 717
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-173
-191
9,4%
-292
-274
-6,4%
427
664
-36%
 
1 018
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-178
-196
9,1%
-297
-280
-6,2%
421
275
53%
 
948
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-175
-193
9,4%
-299
-285
-4,7%
550
463
19%
 
877
 
Net income
M $
Released
Forecast
Spread
-175
-193
9,3%
-299
-284
-5,1%
529
365
45%
 
597
 
EPS
$
Released
Forecast
Spread
-5,76
-2,77
-108%
-2,51
-2,38
-5,3%
3,96
2,74
44%
 
4,37
 
Announcement Date03/26/202002/25/202102/24/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread
104
138
-25%
813
623
30%
1 232
811
52%
-40,6
211
-119%
375
114
228%
 
126
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-52,0
-11,7
-345%
573
958
-40%
1 015
369
175%
-224
12,3
-1 920%
197
237
-17%
 
142
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-53,4
1,30
-4 215%
572
419
37%
1 014
546
86%
-225
69,1
-426%
195
-52,7
470%
 
-58,6
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
111
15,5
617%
546
450
21%
922
588
57%
-234
109
-314%
218
-37,4
682%
 
-48,9
 
Net income
M $
Released
Forecast
Spread
110
12,8
764%
525
353
49%
519
475
9,3%
-76,5
76,4
-200%
175
-8,88
2 074%
 
-55,5
 
EPS
$
Released
Forecast
Spread
0,82
0,08
874%
3,92
2,63
49%
3,85
3,54
8,8%
-0,58
0,26
-324%
1,30
-0,07
2 071%
 
-0,50
 
Announcement Date11/04/202102/24/202205/05/202208/09/202211/03/2022-
Previous year Next Year
Upcoming sector events for VIR BIOTECHNOLOGY, INC.
More events
Past sector events for VIR BIOTECHNOLOGY, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise